Compounds > 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-azido-3'-deoxythymidine
Page last updated: 2024-08-25

5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-azido-3'-deoxythymidine and Acquired-Immune Deficiency Syndrome Dementia Complex

5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-azido-3'-deoxythymidine has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czochralska, B; Kawczynski, W; Lindqvist, L1

Other Studies

1 other study(ies) available for 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-azido-3'-deoxythymidine and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Intermediates in the oxidation of a dihydropyridine derivative of AZT related to AIDS dementia, studied by nanosecond laser photolysis.
    Journal of photochemistry and photobiology. B, Biology, 1994, Volume: 23, Issue:2-3

    Topics: AIDS Dementia Complex; Dihydropyridines; Humans; Lasers; Photolysis; Time Factors; Zidovudine

1994